DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
DisGeNET is a comprehensive discovery platform designed to address a variety of questions concerning the genetic underpinning of human diseases. DisGeNET contains over 380,000 associations between >16,000 genes and 13,000 diseases, which makes it one of the largest repositories currently available of its kind. DisGeNET integrates expert-curated databases with text-mined data, covers information on Mendelian and complex diseases, and includes data from animal disease models. It features a score based on the supporting evidence to prioritize gene-disease associations. It is an open access resource available through a web interface, a Cytoscape plugin and as a Semantic Web resource. The web interface supports user-friendly data exploration and navigation. DisGeNET data can also be analysed via the DisGeNET Cytoscape plugin, and enriched with the annotations of other plugins of this popular network analysis software suite. Finally, the information contained in DisGeNET can be expanded and complemented using Semantic Web technologies and linked to a variety of resources already present in the Linked Data cloud. Hence, DisGeNET offers one of the most comprehensive collections of human gene-disease associations and a valuable set of tools for investigating the molecular mechanisms underlying diseases of genetic origin, designed to fulfill the needs of different user profiles, including bioinformaticians, biologists and health-care practitioners. Database URL: http://www.disgenet.org/
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lysotracker is a fluorescent acidotropic probe for labeling and tracking acidic organelles in live cells, which has been used to detect lysosome localization, quantify the number and sizes of lysosomes48,49 and to monitor autophagy50,51.”
From Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis (2021) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Reactome pathway Knowledgebase
Fabregat, A., Sidiropoulos, K., Garapati, P., Gillespie, M., Hausmann, K., Haw, R., Jassal, B., Jupe, S., Korninger, F., McKay, S., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1351 · Cited by 5,605
The NHGRI GWAS Catalog, a curated resource of SNP-trait associations
Welter, D., MacArthur, J., Morales, J., Burdett, T., Hall, P., Junkins, H., Klemm, A., Flicek, P., Manolio, T., Hindorff, L., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1229 · Cited by 2,707 · cited 1×
“Currently, there are several resources that cover different aspects of our current knowledge on the genetic basis of human diseases (4–11).”
BackgroundThe mechanisms of action of PPARs
Berger, J., & Moller, D. E. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104018 · Cited by 2,659 · cited 2×
“The latter category includes the top three highest scoring diseases, in agreement with the role of PPARG in nutrient levels sensing and the modulation of lipid and glucose metabolism (34).”
BackgroundThe Reactome pathway knowledgebase
Croft, D., Mundo, A. F., Haw, R., Milacic, M., Weiser, J., Wu, G., Caudy, M., Garapati, P., Gillespie, M., Kamdar, M. R., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1102 · Cited by 1,889 · cited 2×
“We also provide information on pathways in which genes participate using the Reactome database (24) (Figure 3b).”
BackgroundMethodActivities at the Universal Protein Resource (UniProt)
(2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1140 · Cited by 1,735
The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene
Tanzi, R. E., Petrukhin, K., Chernov, I., Pellequer, J. L., Wasco, W., Ross, B., Romano, D. M., Parano, E., Pavone, L., Brzustowicz, L. M., et al. (1993) · Nature Genetics · doi:10.1038/ng1293-344 · Cited by 1,375 · cited 1×
“From its initial description in 1912 (28), it has been shown to be related to mutations in the ATP7B gene (29), that encodes a copper transporter of the family of ATPases, leading to copper accumulation.”
BackgroundWILSON, S. A. K. (1912) · Brain · doi:10.1093/brain/34.4.295 · Cited by 1,136
The NCBI dbGaP database of genotypes and phenotypes
Mailman, M. D., Feolo, M., Jin, Y., Kimura, M., Tryka, K., Bagoutdinov, R., Hao, L., Kiang, A., Paschall, J., Phan, L., et al. (2007) · Nature Genetics · doi:10.1038/ng1007-1181 · Cited by 1,105
The Genetic Association Database
Becker, K. G., Barnes, K. C., Bright, T. J., & Wang, S. A. (2004) · Nature Genetics · doi:10.1038/ng0504-431 · Cited by 968 · cited 7×
“In the 2), 48% of GAD and 55% of LHGDN are included in the BeFree associations’ dataset.”
BackgroundMethodInfluentialDisease Ontology: a backbone for disease semantic integration
Schriml, L. M., Arze, C., Nadendla, S., Chang, Y.-W. W., Mazaitis, M., Felix, V., Feng, G., & Kibbe, W. A. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr972 · Cited by 929 · cited 3×
“In addition, we also provide annotations to the Human Disease Ontology (HDO) (26) S1 shows the coverage of DisGeNET diseases with the different disease terminologies and ontologies.”
Method
Research works printed but not linked: 2
- 2014, DAGSTUHL MANIFESTOS, 3, 50
- 2014, BIOMED RES INT, 2014, 253128
Cited by
Items 301–400 of 1,002
Li, X., Lin, Y., Gu, C., & Yang, J. (2019) · BMC Systems Biology · doi:10.1186/s12918-019-0696-9 · Cited by 23
Model annotation and discovery with the Physiome Model Repository
Sarwar, D. M., Kalbasi, R., Gennari, J. H., Carlson, B. E., Neal, M. L., de Bono, B., Atalağ, K., Hunter, P. J., & Nickerson, D. P. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2987-y · Cited by 27
Ma, X., Wang, P., Xu, G., Yu, F., & Ma, Y. (2020) · BMC Medical Genomics · doi:10.1186/s12920-020-00768-z · Cited by 27
“By using the overrepresentation method, we searched the drug-relevant gene sets of these identified genes from two drug databases of DrugBank [42] and GLAD4U [43], and enriched these genes into disease-related gene sets of DisGeNET [44] and GLAD4U [43] databases.”
MethodThe Relationship Between Menopause and Metabolic Syndrome: Experimental and Bioinformatics Analysis
Abir, J., Soltani, I., Bahia, W., Dandana, A., Hasni, Y., Miled, A., & Ferchichi, S. (2021) · Biochemical Genetics · doi:10.1007/s10528-021-10066-7 · Cited by 25
Chen, Y., Lin, L., Hu, C., Zhao, X., Zhang, P., Chang, Y., Shang, Y., Pang, Y., Qian, W., Qiu, X., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.153951 · Cited by 26
Literature evidence in open targets - a target validation platform
Kafkas, Ş., Dunham, I., & McEntyre, J. (2017) · Journal of Biomedical Semantics · doi:10.1186/s13326-017-0131-3 · Cited by 23
Zhang, D., Yu, N., Yuan, Z., Li, W., Sun, X. G., Zou, Q., Li, X., Liu, Z., Zhang, W., & Gao, R. (2024) · GigaScience · doi:10.1093/gigascience/giae089 · Cited by 28
Gálvez, J. M., Castillo-Secilla, D., Herrera, L. J., Román, B. S., Valenzuela, O., Ortuño, F. M., & Rojas, I. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196836 · Cited by 25
Baulina, N., Osmak, G. J., Сергеевич, К. И., Matveeva, N. A., Kukava, N. G., Shakhnovich, R. M., Кулакова, О. Г., & Favorova, O. O. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.07.129 · Cited by 24
Gao, K., Zhu, Y., Wang, H., Gong, X., Yue, Z., Lv, A., & Zhou, X. (2021) · Aging · doi:10.18632/aging.203786 · Cited by 24
“DisGeNET is a versatile platform that comprehensively collects human gene-disease associations (over 380,000 associations between more than 16,000 genes and 13,000 diseases) for the validation of computationally predicted genes for human diseases [22, 23].”
BackgroundB4GALT5 high expression associated with poor prognosis of hepatocellular carcinoma
Yang, H., Li, Z., Wu, Q., Liu, H., Sun, Z., Wu, Y., & Luo, J. (2022) · BMC Cancer · doi:10.1186/s12885-022-09442-2 · Cited by 22
“The results included gene set enrichment analysis in disease association in DisGeNET database [40], transcription factor targets, and tissue/cell type association in PaGenBase database [41].”
MethodKim, B. I., Kim, D., Schulmann, A., Patel, Y., Caban-Rivera, C., Kim, P., Jambhale, A. D., Johnson, K. R., Feng, N., Xu, Q., et al. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.0830-22.2023 · Cited by 23
A network-based trans-omics approach for predicting synergistic drug combinations
Iida, M., Kuniki, Y., Yagi, K., Goda, M., Namba, S., Takeshita, J., Sawada, R., Iwata, M., Zamami, Y., Ishizawa, K., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00571-2 · Cited by 22
“…study 13 , including (i) the Online Mendelian Inheritance in Man (OMIM) database 26 , (ii) ClinVar database 27 , (iii) the genome-wide association studies (GWAS) database 28 , (iv) the phenome-wide association study database (PheWAS) 29 , (v) the GWASdb database 30 ,and(vi)theDisGeNETdatabase 31 .”
Sundarrajan, S., & Arumugam, M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.12.135 · Cited by 22
“In addition, two set of target list was prepared, viz a candidate protein list and a target protein list the former enclosed the drug targets of the approved pharmaceuticals prescribed for the treatment of PV and later enclosed targets mined out from two different microarray gene expression profiles (GSE13355, GSE1490…”
MethodHalu, A., Liu, S., Baek, S. H., Hobbs, B. D., Hunninghake, G. M., Cho, M. H., Silverman, E. K., & Sharma, A. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz069 · Cited by 23
“The expression data were analyzed using the limma package, and Benjamini– Hochberg correction was used to control the FDR. Literaturebased gene sets for COPD and IPF were obtained from the curated disease-gene associations in the DisGeNet database (Version 5.0) using the direct match queries ‘Chronic Obstructive Airwa…”
BackgroundInfluentialMachine learning approaches for predicting biomolecule–disease associations
Ding, Y., Lei, X., Liao, B., & Wu, F. (2021) · Briefings in Functional Genomics · doi:10.1093/bfgp/elab002 · Cited by 24
Inferring disease-associated long non-coding RNAs using genome-wide tissue expression profiles
Pan, X., Jensen, L. J., & Gorodkin, J. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty859 · Cited by 23
A novel subnetwork representation learning method for uncovering disease-disease relationships
Peng, J., Guan, J., Hui, W., & Shang, X. (2020) · Methods · doi:10.1016/j.ymeth.2020.09.002 · Cited by 24
Topel, H., Bağırsakçı, E., Yılmaz, Y., Güneş, A., Bağcı, G., Çömez, D., Kahraman, E., Korhan, P., & Atabey, N. (2021) · Scientific Reports · doi:10.1038/s41598-021-89765-5 · Cited by 24
Li, P., Tiwari, P., Xu, J., Qian, Y., Ai, C., Ding, Y., & Guo, F. (2022) · Knowledge-Based Systems · doi:10.1016/j.knosys.2022.110044 · Cited by 23
Bernaola, N., Michiels, M., Larrañaga, P., & Bielza, C. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011443 · Cited by 24
Dietzsch, A. N., Al‐Hasani, H., Altschmied, J., Bottermann, K., Brendler, J., Haendeler, J., Horn, S., Kaczmarek, I., Körner, A., Krause, K., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01810-7 · Cited by 23
“74 In vitro analysis of the two rare variants show that residual receptor activity is retained in both variants, which is in line that complete loss-of-function mutations is not well compatible with healthy life.”
BackgroundBenjamin, K. J., Arora, R., Feltrin, A. S., Pertea, G. M., Giles, H. H., Stolz, J. M., D’Ignazio, L., Collado‐Torres, L., Shin, J. H., Ulrich, W. S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48048-z · Cited by 30
“Here, we found the majority (544 [77”
MethodInfluentialGLADIATOR: a global approach for elucidating disease modules
Silberberg, Y., Kupiec, M., & Sharan, R. (2017) · Genome Medicine · doi:10.1186/s13073-017-0435-z · Cited by 21
“…all parameter and random seed configurations yielded highly enriched modules compared to known disease-associated genes obtained from DisGeNET [26] (see ” Performance evaluation ’ ), with enrichment vs. ‘ Curated ’ ranging between 8.1e -58 to 3.5e -85 for different seed configurations, and…”
BackgroundMethodFreytag, S., Burgess, R., Oliver, K. L., & Bahlo, M. (2017) · Genome Medicine · doi:10.1186/s13073-017-0444-y · Cited by 28
“Most web-based prioritisation tools already integrate databases such as OMIM, DisGeNet [39] and KEGG in order to improve their performance.”
MethodA TRPV2 interactome-based signature for prognosis in glioblastoma patients
Doñate‐Macian, P., Gómez, A., Degano, I. R., & Perálvarez‐Marín, A. (2018) · Oncotarget · doi:10.18632/oncotarget.24843 · Cited by 21
“All genes except for Opalin and Snapin were identified in the Disgenet database [16].”
BackgroundMethodRondeau, G., Abedinpour, P., Chrastina, A., Pelayo, J. T., Borgström, P., & Welsh, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-20451-9 · Cited by 22
Sanchez-Pozos, K. A., Ortiz‐López, M. G., Peña‐Espinoza, B. I., Granados‐Silvestre, M. D. L. Á., Jacinto, V. J., Verleyen, J., Ayele, F. T., Sánchez‐Flores, A., & Menjívar, M. (2018) · Molecular Genetics and Genomics · doi:10.1007/s00438-018-1453-2 · Cited by 24
Cabrera‐Andrade, A., López‐Cortés, A., Jaramillo-Koupermann, G., Paz‐y‐Miño, C., Pérez‐Castillo, Y., Munteanu, C. R., González‐Díaz, H., Pazos, A., & Tejera, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031053 · Cited by 23
“The bioinformatics methods used in this study were for gene-disease prioritization Biograph [86], Cipher [87], DisGeNET [88], Génie [89], GLAD4U [90], Guildify [91], Phenolizer [92], PolySearch [93], and SNPs3D [94].”
MethodSumathipala, M. G., & Weiss, S. T. (2020) · Scientific Reports · doi:10.1038/s41598-020-65633-6 · Cited by 26
“We combine 28,488 gene-disease associations from OMIM and GWAS databases 34 , 141,296 protein-protein interactions 24 , and 319,791 miRNA-gene interactions from the miRTar database to form a tripartite network (Fig.”
MethodAstro, V., Alowaysi, M., Fiacco, E., Saera-Vila, A., Cardona‐Londoño, K. J., Cigliano, R. A., & Adamo, A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.801597 · Cited by 24
“0 (Piñero et al., 2015; Piñero et al., 2016; Piñero et al., 2019) as database for genes associated to human diseases on the commonly X-linked DEGs from the comparisons 47,XXY vs.”
BackgroundComputational approaches for innovative antiepileptic drug discovery
Talevi, A. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1216965 · Cited by 23
“For instance, DisGeNET [172] is a discovery platform that contains hundreds of thousands of associations between genes and diseases (including both Mendelian and complex disorders).”
BackgroundTejera, E., Cruz‐Monteagudo, M., Burgos, G., Sánchez, M.-E., Sánchez‐Rodríguez, A., Pérez‐Castillo, Y., Borges, F., Cordeiro, M. N. D. S., Paz‐y‐Miño, C., & Rebelo, I. (2017) · BMC Medical Genomics · doi:10.1186/s12920-017-0286-x · Cited by 24
“Under these conditions we found 12 methods: Biograph [17], Candid [18], Glad4U [19], PolySearch [20], Cipher [21], Guildify [22], DisgeNet [23], GeneProspector [24], Genie [25], SNPs3D [26], GeneDistiller [27] and MetaRanker [28].”
MethodDISGENET: Accelerating Data-Driven Discovery in Disease Genomics and Therapeutic DevelopmentPreprint
Piñero, J., Corvi, J., Rykova, N., Guillem, A., Martínez, A., Zufiaur, J. T., Rivetta, I., Holmes, S., Boccio, M. D., Shapoval, D., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.05.697749 · Cited by 26
Self-citationSivakumar, T. R., Surendhiran, D., Chen, K., Lv, P., Vinothkanna, A., Prathiviraj, R., Sethupathy, S., & Razack, S. A. (2021) · South African Journal of Botany · doi:10.1016/j.sajb.2021.01.034 · Cited by 20
Role of Oligodendrocyte Lineage Cells in Multiple System Atrophy
Hsiao, J.-H. T., Tanglay, O., Li, A. A., Strobbe, A. Y. G., Kim, W. S., Halliday, G. M., & Fu, Y. (2023) · Cells · doi:10.3390/cells12050739 · Cited by 22
“Risk genes were extracted from the literature, DisGeNet [120] and the Harmonizome database [121], and subsequently used Brain RNA-Seq [23] to determine the oligodendrocyte-specific expression of these genes in humans, though data for OPCs were not available.”
MethodYe, J., Wu, J., Ai, L., Zhu, M., Li, Y., Yin, D., & Huang, Q. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116296 · Cited by 22
Shen, Z., Bao, N., Chen, J., Tang, M., Yang, L., Yang, Y., Zhang, H., Han, J., Yu, P., Zhang, S., et al. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110153 · Cited by 20
Wilson, J. L., Racz, R., Liu, T., Adeniyi, O., Sun, J., Ramamoorthy, A., Pacanowski, M. A., & Altman, R. B. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006614 · Cited by 24
“Relevant resources that could collectively inform a drug target’s phenome include Pharmacogenomics Knowledgebase (PharmGKB)[6], genome-wide association studies (GWAS)[7], Online Mendelian Inheritance in Man (OMIM)[8], disease-gene associations such as DisGeNet[9,10], and phenotype-gene association studies (PheWAS)[11,…”
BackgroundMethodBorges, R., Fonseca, J., Gomes, C., Johnson, W. E., O’Brien, S. J., Zhang, G., Gilbert, M. T. P., Jarvis, E. D., & Antunes, A. (2019) · Genome Biology and Evolution · doi:10.1093/gbe/evz111 · Cited by 26
Connectivity Significance for Disease Gene Prioritization in an Expanding Universe
Petti, M., Bizzarri, D., Verrienti, A., Falcone, R., & Farina, L. (2019) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2019.2938512 · Cited by 21
On the hunt for the alternate host of Hemileia vastatrix
Koutouleas, A., Jørgensen, H. J. L., Jensen, B., Lillesø, J. B., Junge, A., & Ræbild, A. (2019) · Ecology and Evolution · doi:10.1002/ece3.5755 · Cited by 20
“Automated text mining of the biomedical literature has been widely used to recognize entities such as species, proteins, or diseases in the scholarly literature, for example, (Pafilis et al., 2013; Piñero et al., 2015).”
MethodAltaf‐Ul‐Amin, M., Karim, M. B., Hu, P., Ono, N., & Kanaya, S. (2020) · BMC Medical Genomics · doi:10.1186/s12920-020-0660-y · Cited by 20
“We also downloaded IBD related genes from other online sources such as HuGENet [17], Comparative Toxicogenomics Database(CTD) [18], DisGeNet [19] and literatures related to genome wide association study (GWAS) [20–23].”
MethodThe influence of rare variants in circulating metabolic biomarkers
Riveros-Mckay, F., Oliver‐Williams, C., Karthikeyan, S., Walter, K., Kundu, K., Ouwehand, W. H., Roberts, D. J., Angelantonio, E. D., Soranzo, N., Danesh, J. N., et al. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008605 · Cited by 20
“To perform gene set analysis we obtained a curated gene-disease list from DisGeNET [61, 62] and gene lists of metabolic pathways from KEGG [63-65] and Reactome [66, 67] (Supplementary Table 3).”
MethodA network-based machine-learning framework to identify both functional modules and disease genes
Yang, K., Lu, K., Wu, Y., Yu, J. Q., Liu, B., Zhao, Y. C., Chen, J., & Zhou, X. (2021) · Human Genetics · doi:10.1007/s00439-020-02253-0 · Cited by 22
“Disease–gene associations: DisGeNet (Piñero et al. 2015) is an integrated database that contains many genes and variants associated with human diseases from multiple databases, e.g., PsyGeNET (Gutiérrezsacristán et al. 2015), ClinVar (Landrum et al. 2014), Orphanet (Mangon et al. 2008) and the GWAS…”
BackgroundInfluentialDecoding multilevel relationships with the human tissue-cell-molecule network
Hou, S., Zhang, P., Yang, K., Wang, L., Ma, C., Li, Y., & Li, S. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac170 · Cited by 21
Integrating Biological Networks for Drug Target Prediction and Prioritization
Ji, X., Freudenberg, J., & Agarwal, P. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8955-3_12 · Cited by 20
Publishing DisGeNET as nanopublications
Queralt-Rosinach, N., Kuhn, T., Chichester, C., Dumontier, M., Sanz, F., & Furlong, L. I. (2016) · Semantic Web · doi:10.3233/sw-150189 · Cited by 19
Self-citationCao, Y., Lu, X., Wang, J., Zhang, H., Liu, Z., Xu, S., Wang, T., Ning, S., Xiao, B., & Wang, L. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.2853 · Cited by 19
“In addition, we also collected MG risk genes from current public databases, including the Genetic Association Database (GAD) (17), DisGeNET (18), Online Mendelian Inheritance in Man (OMIM) (19) and Functional Disease Ontology Annotation (FunDO) (20).”
MethodWhole Genome Sequence, Variant Discovery and Annotation in Mapuche-Huilliche Native South Americans
Vidal, E. A., Moyano, T. C., Bustos, B. I., Pérez‐Palma, E., Moraga, C., Riveras, E., Montecinos, A., Azócar, L., Soto, D. C., Vidal, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-39391-z · Cited by 20
Integrative OMICS Data-Driven Procedure Using a Derivatized Meta-Analysis Approach
Cervantes-Gracia, K., Chahwan, R., & Husi, H. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.828786 · Cited by 19
Röhl, A., Baek, S. H., Kachroo, P., Morrow, J. D., Tantisira, K. G., Silverman, E. K., Weiss, S. T., Sharma, A., Glass, K., & DeMeo, D. L. (2022) · Respiratory Research · doi:10.1186/s12931-022-01963-5 · Cited by 22
“Genes that can be associated to asthma and/or COPD according to DisGeNet are highlighted in green.”
MethodInfluentialOnisiforou, A., & Spyrou, G. M. (2022) · Viruses · doi:10.3390/v14102270 · Cited by 19
“Therefore, to identify if genetic susceptibility genes of the thirteen diseases/disorders under investigation interact with SARS-CoV-2 viral proteins, we first collected from DisGeNET database [47,48] their disease-associated variants, retaining only those with available gene name and removing duplicated gene names.”
BackgroundLamberto, F., Shashikadze, B., Elkhateib, R., Lombardo, S. D., Horánszky, A., Balogh, A., Kistamás, K., Zana, M., Menche, J., Fröhlich, T., et al. (2023) · Environmental Pollution · doi:10.1016/j.envpol.2023.122359 · Cited by 20
Bravo‐Jaimes, K., Wu, X., Reardon, L. C., Lluri, G., Lin, J. P., Moore, J. P., Arsdell, G. V., Biniwale, R. M., Si, M., Naini, B. V., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.12.005 · Cited by 20
Asim, M. N., Ibrahim, M. A., Zaib, A., & Dengel, A. R. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1503229 · Cited by 20
Fusing literature and full network data improves disease similarity computation
Li, P., Nie, Y., & Yu, J. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-1205-4 · Cited by 21
“SIDD [26] and DisGeNET [27] were adopted as two disease-gene association databases (Fig.”
MethodDevelopment of zebrafish medulloblastoma-like PNET model by TALEN-mediated somatic gene inactivation
Shim, J., Choi, J., Park, M.-H., Kim, H., Kim, J.-H., Kim, S., Hong, D., Kim, S., Lee, J. E., Kim, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19424 · Cited by 20
Leng, L., Zhang, C., Ren, L., & Li, Q. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.4026 · Cited by 19
“GDM-associated gene data were downloaded from DisGeNET, a discovery platform containing one of the largest publicly available collections of genes and variants associated with human diseases (22).”
Fan, X., Chen, Y., Li, W., Xia, H., Liu, B., Guo, H., Yang, Y., Xu, C., Xie, S., & Xu, X. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.590605 · Cited by 20
“DisGeNET, a discovery platform for the dynamical exploration of human diseases and their associated genes, is considered as a good tool for investigating the molecular mechanisms underlying diseases of genetic origin (Pinero et al., 2015).”
BackgroundLlorach-Parés, L., Nonell‐Canals, A., Àvila, C., & Sánchez-Martínez, M. (2022) · Marine Drugs · doi:10.3390/md20010053 · Cited by 19
“Mar. Drugs 2021, 19, x 5 of 26 Thereafter, by using DisGeNET [37], we checked the possible therapeutic indication of each molecule by analyzing the diseases on which the predicted targets may be involved.”
MethodInfluentialCapalbo, A., Buonaiuto, S., Figliuzzi, M., Damaggio, G., Girardi, L. D. C., Caroselli, S., Poli, M., Patassini, C., Çetinkaya, M., Yüksel, B., et al. (2022) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2022.05.009 · Cited by 19
Personalized Medicine: A Review with Regard to Biomarkers
Foroutan, B. (2015) · Journal of Bioequivalence & Bioavailability · doi:10.4172/jbb.1000248 · Cited by 22
A Trusted Healthcare Data Analytics Cloud Platform
Iyengar, A., Kundu, A., Sharma, U. K., & Zhang, P. (2018) · IEEE International Conference on Distributed Computing Systems (ICDCS) · doi:10.1109/icdcs.2018.00123 · Cited by 19
“We also make use of scientific databases such as the DisGeNet database of genes and variants involved in human diseases [15], the PubChem database of chemical structures [16], the DrugBank database on drug and drug targets [17] and the SIDER database on drug side effects [18].”
MethodTang, R., Zhang, J., Nan, H., Lv, R., Chen, X., Liu, Y., Wang, X., & Wang, L. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/6225758 · Cited by 19
“Constipation-associated target genes were collected from databases including GeneCards [22], OMIM [23], and DisGeNET [24], which were searched using the keyword “constipation.”
MethodFang, Y., Lin, S., Dou, Q., Gui, J., Li, W., Tan, H., Wang, Y., Zeng, J., Khan, A., & Wei, D. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2167114 · Cited by 18
“The DisGeNET database (score > 0.1), GeneCards database (score > 1), and Therapeutic Target Database (TTD) were used to determine targets related to sepsis.”
MethodInfluentialZhao, W., Wang, Z., Shi, R., Zhu, Y., Li, X.-L., & Wang, D. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-03976-z · Cited by 18
Joo, Y. B., Kim, Y., Park, Y., Kim, K.-W., Ryu, J. A., Lee, S., Bang, S., Lee, H., Yi, G.-S., & Bae, S. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1414-x · Cited by 18
“We collected prior gene-disease association (GDA) from DisGeNet [20] and disease similarity (DS) from MimMiner [21] to consider not only RA genes, but also genes for RA-related diseases.”
MethodINTEGRO: an algorithm for data-integration and disease-gene association
Cinaglia, P., Guzzi, P. H., & Veltri, P. (2018) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2018.8621193 · Cited by 18
“UniProt, GWAS Catalog, Comparative Toxicogenomics Database) and scientific literature, has been released by DisGeNET in order to provide a set of gene-disease associations [19].”
MethodRecamonde‐Mendoza, M., Werhli, A. V., & Biolo, A. (2019) · Gene · doi:10.1016/j.gene.2019.02.056 · Cited by 18
Multivariable regulation of gene expression plasticity in metazoans
Xiao, L., Zhao, Z., He, F., & Du, Z. (2019) · Open Biology · doi:10.1098/rsob.190150 · Cited by 18
“Gene-disease associations were extracted from GeneCards (68) and DisGeNet (66).”
MethodRaj, A., & Powell, F. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118008 · Cited by 18
“database, which generates integrated human gene-disease associations from curated databases and text mining (Piñero et al., 2015).”
Qiu, Y., Fang, B., Thủy, N. T. T., Li, A., Yoo, H. M., Zheng, X., & Cho, N. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174669 · Cited by 18
FocusHeuristics – expression-data-driven network optimization and disease gene prediction
Ernst, M., Du, Y., Warsow, G., Hamed, M., Endlich, N., Endlich, K., Escobar, H. M., Sklarz, L.-M., Sender, S., Junghanß, C., et al. (2017) · Scientific Reports · doi:10.1038/srep42638 · Cited by 18
Jagannathan, R., Seixas, A. A., St‐Jules, D. E., Jagannathan, L., Rogers, A., Hu, L., Jean‐Louis, G., & Sevick, M. A. (2017) · Sleep Disorders · doi:10.1155/2017/6768323 · Cited by 21
Yasukochi, Y., Sakuma, J., Takeuchi, I., Kato, K., Oguri, M., Fujimaki, T., Horibe, H., & Yamada, Y. (2017) · Zeitschrift für Induktive Abstammungs- und Vererbungslehre · doi:10.1007/s00438-017-1394-1 · Cited by 21
“org/web/DisGeNET/, (Piñero et al. 2015)], GWAS Catalogue [https://www.”
DEXTER: Disease-Expression Relation Extraction from Text
Gupta, S., Dingerdissen, H., ROSS, K. E., Hu, Y., Wu, C. H., Mazumder, R., & Vijay‐Shanker, K. (2018) · Database · doi:10.1093/database/bay045 · Cited by 19
“DisGeNET (17, 18) is a comprehensive platform on human genotype–phenotype relationships, which integrates data from expert curated databases with information gathered through text-mining the scientific literature.”
BackgroundLigand- and Structure-Based Drug Design and Optimization using KNIME
Mazanetz, M. P., Goode, C. H. F., & Chudyk, E. I. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190409141016 · Cited by 21
Michaelovsky, E., Carmel, M., Frisch, A., Salmon‐Divon, M., Pasmanik, M., Weizman, A., & Gothelf, D. (2019) · Translational Psychiatry · doi:10.1038/s41398-018-0354-9 · Cited by 18
Molinski, S. V., Shahani, V. M., MacKinnon, S. S., Morayniss, L. D., Laforet, M., Woollard, G., Kurji, N., Sanchez, C. G., Wodak, S. J., & Windemuth, A. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.115 · Cited by 17
Digles, D., Zdrazil, B., Neefs, J., van Vlijmen, H., Herhaus, C., Caracoti, A., Brea, J. M., Roibás, B., Loza, M. I., Queralt-Rosiñach, N., et al. (2016) · MedChemComm · doi:10.1039/c6md00065g · Cited by 18
Self-citationYu, M., Song, X., Ma, X., Hao, C., Huang, J., & Yang, W. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-20-1384 · Cited by 18
“21037/apm-20-1384 curated repositories, scientific literature, and genome-wide association study catalogs (21).”
BackgroundChen, G., Wang, Y., Yu, X., Liu, X., Chen, J., Luo, J., & Tao, Q. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/1826299 · Cited by 32
“-e OA-related genes were collected from GeneCards [29], online mendelian inheritance in man (OMIM) [30], GeneBank, therapeutic target database (TTD) [31] and DisGeNET databases [32] using the keyword “osteoarthritis.”
MethodZamora, Z., Wang, S. S.-M., Chen, Y.-W., Diamante, G., & Yang, X. (2023) · Environment International · doi:10.1016/j.envint.2023.108339 · Cited by 18
Mechanism of cytarabine-induced neurotoxicity
Liu, J., Wang, D., Callén, E., Chen, C., Noriega, S., Shang, Y., Schürmann, D., Song, Y., Ramadoss, G. N., Chari, R., et al. (2025) · Nature · doi:10.1038/s41586-025-09210-9 · Cited by 18
“KEGG pathway and DisGeNET database enrichment analyses were performed using the Bioconductor clusterProfiler package (v4.”
Computational Prediction of Protein Complexes from Protein Interaction Networks
Srihari, S., Yong, C. H., & Wong, L. (2017) · doi:10.1145/3064650 · Cited by 19
The Antiretroviral Agent Nelfinavir Mesylate
Sánchez, C. G., Molinski, S. V., Gongora, R., Sosulski, M. L., Fuselier, T. T., MacKinnon, S. S., Mondal, D., & Lasky, J. A. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40326 · Cited by 17
Contextualized Protein-Protein Interactions
Federico, A. N., & Monti, S. (2020) · Patterns · doi:10.1016/j.patter.2020.100153 · Cited by 19
Similarities and dissimilarities between psychiatric cluster disorders
Smail, M. A., Wu, X., Henkel, N., Eby, H., Herman, J. P., McCullumsmith, R. E., & Shukla, R. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01030-3 · Cited by 18
“To look for molecularly similar diseases, we calculated a pairwise similarity matrix for 763 disease-associated gene-sets from DisGeNET (Figure 1A).”
InfluentialBordeira–Carriço, R., Teixeira, J., Duque, M., Galhardo, M., Ribeiro, D. M., Acemel, R. D., Firbas, P., Tena, J. J., Eufrásio, A., Marques, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29551-7 · Cited by 18
Gómez-Rubio, P., Piñero, J., Molina‐Montes, E., Gutiérrez‐Sacristán, A., Márquez, M., Rava, M., Michalski, C. W., Farré, A., Molero, X., Löhr, M. J., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31866 · Cited by 17
Self-citationDong, S., Ding, Z., Zhang, H., & Chen, Q. (2019) · Integrative Cancer Therapies · doi:10.1177/1534735419864434 · Cited by 18
Xia, J., Yin, F., Fang, J., Lou, G., Yu, J., Xu, Z., Yuan, Y., Tinggang, Z., Xiaodan, Z., & Zongsuo, L. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-04048-y · Cited by 16
“Use “Liver cancer” as the key words, the liver cancer related genes were screened out by DisGeNET [31], GeneCards [32], OMIM [33].”
MethodInfluentialGe, X., Zhang, Y., Fang, R.-L., Zhao, J., & Huang, J. (2023) · Medicine · doi:10.1097/md.0000000000034396 · Cited by 17
““Gout” was used as a keyword to search the DisGeNET (https://www.disgenet.org/) [19] database and the OMIM (https://omim.org/) [20] database, and the same genes were deleted from both databases to obtain the final gout-related genes.”
MethodXA4C: eXplainable representation learning via Autoencoders revealing Critical genes
Li, Q., Yu, Y., Kossinna, P., Lun, T., Liao, W., & Zhang, Q. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011476 · Cited by 16
“We then examined the DisGeNET [35], a 231 comprehensive database for the enrichment of these three categories of genes (Materials & 232”
MethodInfluentialDrug Repurposing: Insights into Current Advances and Future Applications
Bhatia, T., & Sharma, S. (2023) · Current Medicinal Chemistry · doi:10.2174/0109298673266470231023110841 · Cited by 19
Dongre, P., & Majumdar, A. S. (2024) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2024.100902 · Cited by 24
“This helped in collecting relevant information on various diseases condition [33,34].”
BackgroundChowdhury, M. R., Karamveer, K., Tiwary, B. K., Nampoothiri, N. K., Erva, R. R., & Vijaykumar, S. D. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-024-01460-2 · Cited by 18
“…of the molecular intricacies at play but also provides a comprehensive landscape of potential therapeutic pathways influenced by BHD in the context of Alzheimer’s disease. database (https://www.disgenet.org/ ) (Pinero et al. 2015 ), and GeneCards ( https://www.genecards.org/) (Safran et al. 2010).”
Shi, J., Huang, H., Zhang, Y., Long, Y., & Yiu, S. (2017) · BMC Medical Genomics · doi:10.1186/s12920-017-0305-y · Cited by 16
Navigating the disease landscape: knowledge representations for contextualizing molecular signatures
Saqi, M. A. S., Lysenko, A., Guo, Y., Tsunoda, T., & Auffray, C. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bby025 · Cited by 19
Metadata
- Authors
- Pinero, J., Queralt-Rosinach, N., Bravo, A., Deu-Pons, J., Bauer-Mehren, A., Baron, M., Sanz, F., & Furlong, L. I.
- Affiliations
- Universitat Pompeu Fabra (ES)
- Corresponding author
- Furlong, L. I.
- Venue
- Database
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-04-15
- Volume
- 2015
- Issue
- 0
- Pages
- bav028-bav028
- ISSN
- 1758-0463 (ISSN-L)
- PMC
- PMC4397996
- OpenAlex
- W2144086069
- Cited by
- 1,124
- References
- 50
- Citations by year
- 2026: 49 · 2025: 96 · 2024: 110 · 2023: 125 · 2022: 121 · 2021: 95 · 2020: 100 · 2019: 116 · 2018: 97 · 2017: 130 · 2016: 65 · 2015: 19
- FWCI
- 45.04
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Database (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (publishedVersion, other-oa)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion, cc-by)
- Funders
- European Federation of Pharmaceutical Industries and Associations (FP7/20072013, 115002)
- European Commission (2007–2013, FP7 2007-2013, 115002, FP7/2007, 115191)
- Innovative Medicines Initiative (FP7/2007‐2013, 115002)
- Instituto de Salud Carlos III (115191, PI13/00082, CP10/00524, 115002)
- European Regional Development Fund (FP7/2007‐2013, 2007 – 2013)
- Topics
- Health Sciences › Medicine › Health Informatics › Biomedical Text Mining and Ontologies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- gene-disease association, human disease, genetic basis of disease, monogenic disorders, complex diseases, animal disease models, Cytoscape plugin, semantic web, linked data, disease networks
- MeSH terms
- Cloud Computing, Animals, Disease Models, Animal, Humans, User-Computer Interface, Genome, Human, Internet, Genetic Diseases, Inborn, Databases, Genetic, Gene Regulatory Networks
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.